QbD Group
    Request auditContact us
    Project / Partnership

    ATMP XB: Advancing Cell & Gene Therapy in the Flemish-Dutch Border Region

    A cross-border Interreg project co-funded by the European Union

    ATMP XB — Interreg Vlaanderen-Nederland — Co-funded by the European Union

    QbD Group is a partner in ATMP XB, an EU co-funded project dedicated to strengthening the Flemish-Dutch border region as a leading hub for advanced therapy medicinal products. Through cross-border collaboration between universities, hospitals and industry partners, ATMP XB works to bring innovative cell and gene therapies to patients faster and more safely.

    14 partners

    Universities, hospitals and companies

    3 years

    November 2025 to October 2028

    €3.49M

    Total project budget

    Background

    What are ATMPs?

    Advanced therapy medicinal products (ATMPs) include cell therapies, gene therapies and tissue-engineered products. These therapies use living cells or genetically modified material to treat severe or currently incurable diseases, including certain cancers, rare genetic disorders and chronic inflammatory conditions. They represent one of the most promising frontiers in modern medicine.

    The project

    About the project

    ATMP XB brings together educational institutions, hospitals and life sciences companies across the Flemish-Dutch border region to tackle the key challenges standing between ATMP innovation and patient access. As a life sciences consultancy with deep expertise in regulatory affairs, quality assurance and qualification and validation, QbD Group contributes to the project's mission of building a reliable, compliant and scalable ATMP ecosystem in the region.

    Four focus areas

    Four interconnected pillars

    The project focuses on four areas that together strengthen the regional ATMP ecosystem.

    Production Processes

    Improving the way ATMPs are manufactured to ensure scalability and reliability.

    Quality Control

    Strengthening quality systems to meet the strict standards required for advanced therapies.

    Technology Development

    Accelerating innovation in the tools and techniques that bring new therapies to patients.

    Specialised Training

    Building the skilled workforce the ATMP sector needs across the border region.

    A European initiative

    ATMP XB is co-funded by the European Union through the Interreg Vlaanderen-Nederland programme, which supports cross-border collaboration between Flanders and the Netherlands. The project is part of the "A Smarter Europe" theme, focused on innovation and skills for smart transformation.